Information Journal Paper
APA:
Copy. (2017). Assessment of lower doses of intravitreous bevacizumab for retinopathy of prematurity: a phase 1 dosing study. JAMA OPHTHALMOLOGY, 135(6), 654-656. SID. https://sid.ir/paper/737196/en
Vancouver:
Copy. Assessment of lower doses of intravitreous bevacizumab for retinopathy of prematurity: a phase 1 dosing study. JAMA OPHTHALMOLOGY[Internet]. 2017;135(6):654-656. Available from: https://sid.ir/paper/737196/en
IEEE:
Copy, “Assessment of lower doses of intravitreous bevacizumab for retinopathy of prematurity: a phase 1 dosing study,” JAMA OPHTHALMOLOGY, vol. 135, no. 6, pp. 654–656, 2017, [Online]. Available: https://sid.ir/paper/737196/en